Mrs. Barbara Browne, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 163 Silver St, Waterville, ME 04901 Phone: 207-877-2498 |
Mrs. Kristina Marie Guerette Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 163 Silver St, Waterville, ME 04901 Phone: 207-877-2498 Fax: 207-877-7459 |
Roberta Ratner Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 149 North St, Waterville, ME 04901 Phone: 207-872-4303 Fax: 207-872-4294 |
Mrs. Robin Anne Kornmuller, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 325e Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-877-2498 |
Mrs. Charlene Marie Southwick, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 163 Silver St, Waterville, ME 04901 Phone: 207-877-2498 |
Tara Knapp Adams, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 155 Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-872-5775 Fax: 207-872-6116 |
Katie Gerrish, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 155 Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-872-5775 Fax: 207-872-6116 |
Ms. Leese Thomas Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 Cool St, Waterville, ME 04901 Phone: 207-873-0721 |
Nancy Couture, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 W River Rd, Waterville, ME 04901 Phone: 207-873-2144 |
Kathy E Merrill, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 58 Drummond Ave, Waterville, ME 04901 Phone: 207-873-0695 |
Ayla C Vanclief, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 155 Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-872-5775 |
Sharon Peabody Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 Messalonskee Ave, Waterville, ME 04901 Phone: 207-873-4281 |
Louise Nelson Hamelin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 58 Drummond Ave, Waterville, ME 04901 Phone: 207-873-0695 |
Robin L Corey, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 Messalonskee Ave, Waterville, ME 04901 Phone: 207-872-4281 |
Deborah Jane Packard Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 325e Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-877-2498 Fax: 207-877-7458 |
Mrs. Sarah J. Ramgren, S.L.P - C.C.C. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 Messalonskee Ave, Waterville, ME 04901 Phone: 207-873-4281 Fax: 207-859-2342 |
Bethany Justine Roderigue Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 Cool St, Waterville, ME 04901 Phone: 207-873-0721 |
Kathryn J Hill Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 325e Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-877-2498 |
News Archive
Fetal Alcohol Research, the official journal of FACE, has published breakthrough research by Dr. Sterling Clarren, CEO and Chief Scientific Officer of Canada Northwest FASD Research Network and colleagues, establishing Canadian norms which will allow more accurate diagnosis of Fetal Alcohol Spectrum Disorder (FASD).
Researchers at the University of Gothenburg, Sweden, have identified two genes believed to play a role in the development of endometrial cancer. These results may eventually lead to better diagnosis and treatment of this increasingly common form of cancer.
Stem cells are the basic material from which mature, specialised cells such as muscle and blood cells are produced - this process is known as differentiation.
Bristol-Myers Squibb Company and AstraZeneca today announced results from an investigational Phase 3b clinical study in which the addition of ONGLYZA (saxagliptin) 5 mg to ongoing insulin therapy (with or without metformin) maintained reductions of blood sugar levels (glycosylated hemoglobin levels, or HbA1c) in adult patients with type 2 diabetes compared to the addition of placebo (with or without metformin) from 24 to 52 weeks.
Researchers at the Joslin Diabetes Center have shown for the first time that insulin plays a key role in suppressing levels of glucagon, a hormone involved in carbohydrate metabolism and regulating blood glucose levels.
› Verified 8 days ago